store at low temperature
store at -20°C
Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody.Golimumab has anti-inflammatory and anticancer activity, inhibits the production of IL-6 and IL-1β, and induces apoptosis.Golimumab can be used to prevent inflammation and destruction of cartilage or bone, and can be used to study rheumatoid arthritis and cancer. Golimumab can be used to prevent inflammation and cartilage or bone destruction and can be used to study rheumatoid arthritis and cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 297.00 | |
5 mg | In stock | $ 689.00 | |
10 mg | In stock | $ 973.00 | |
25 mg | In stock | $ 1,430.00 | |
50 mg | In stock | $ 1,930.00 | |
100 mg | In stock | $ 2,630.00 |
Description | Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody.Golimumab has anti-inflammatory and anticancer activity, inhibits the production of IL-6 and IL-1β, and induces apoptosis.Golimumab can be used to prevent inflammation and destruction of cartilage or bone, and can be used to study rheumatoid arthritis and cancer. Golimumab can be used to prevent inflammation and cartilage or bone destruction and can be used to study rheumatoid arthritis and cancer. |
In vitro | Inducing reductions in the viability of transmembrane TNFα–expressing cells, Golimumab (CNTO-148) (0.1-10 μg/mL; 24-72 hours; transmembrane TNFα–transfected Jurkat cells) [1].Inducing apoptosis, increasing the levels of active caspase-3, and inducing apoptotic DNA fragmentation, Golimumab (CNTO-148) (10 μg/mL; 48 hours; transmembrane TNFα–transfected Jurkat cells) [1]. |
In vivo | Golimumab (CNTO-148), administered intraperitoneally at doses of 1-10 mg/kg daily for 4 weeks in the Tg197 transgenic mouse model, relieves TNFα-induced arthritis in a mouse model of humans [3].Golimumab (CNTO-148), administered intravenously at a dose of 24 mg/kg daily for 7 days in Swiss-albino healthy male mice, inhibits oxidative stress, apoptotic cell death, and inflammatory response, thereby improving renal function. Golimumab reduces all markers of kidney injury and attenuates cell death [3]. |
Synonyms | MK-8259, SCH 900259, CNTO-148 |
Molecular Weight | N/A |
CAS No. | 476181-74-5 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Golimumab 476181-74-5 Apoptosis TNF MK-8259 SCH 900259 CNTO-148 inhibitor inhibit